NCT04726982View on ClinicalTrials.gov

Optimal Dosage of Acetazolamide for OSA Treatment

PHASE4CompletedINTERVENTIONAL

Enrollment

91

Participants

Timeline

Start Date

April 20, 2021

Primary Completion Date

March 19, 2024

Study Completion Date

May 5, 2024

Conditions

Obstructive Sleep Apnea

Interventions

DRUG

Acetazolamide

250 mg once daily

DRUG

Acetazolamide

500 mg once daily

OTHER

Placebo

Once daily

Trial Locations (1)

2650

Antwerp University Hospital, Edegem

All Listed Sponsors

lead

University Hospital, Antwerp

OTHER